Lucid Capital Markets Downgrades INmune Bio Inc. (INMB) to Neutral

June 30, 2025 4:01 PM

Lucid Capital Markets analyst Elemer Piros downgraded INmune Bio Inc. (NASDAQ: INMB) from Buy to Neutral with a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found